领先的COVID-19疫苗的比较疗效:一个网络元分析
Sanjay Rai1, Shashank Tripathi2
1Department of Centre of Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
The Indian journal of medical research
|March 4, 2025
概括
斯派克瓦克斯证明了针对COVID-19的最高疫苗疗效,其P分数为0.95.5. 这项研究比较了15种疫苗,提供了清晰的疫苗在控制大流行中的有效性排名.
科学领域:
- 免疫学和传染病的研究
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- COVID-19疫苗使用多种技术,包括mRNA,病毒载体,蛋白质子单元和非活化病毒.
- 疫苗的有效性对于控制SARS-CoV-2大流行病的传播至关重要.
- 对不同疫苗平台的比较分析对于明智的公共卫生战略至关重要.
研究的目的:
- 为了比较各种COVID-19疫苗在控制流行病传播方面的有效性.
- 根据疗效提供领先的候选疫苗的清晰排名.
- 通过网络元分析分析疫苗疗效的直接和间接估计.
主要方法:
- 进行了PubMed,EMBASE和Cochrane图书馆的广泛文献审查,截至2023年4月30日.
- 采用频率网络元分析来比较疫苗的疗效.
- 包括来自26篇文章的15种不同的疫苗的数据.
主要成果:
- 斯派克瓦克斯 (Spikevax) 的疗效最高 (VE: 93.29%),其次是瑞生物科技 (Pfizer BioNTech) (VE: 92.07%) 和斯普特尼克 (Sputnik) (VE: 91.60%).
- 对所有15种分析的疫苗获得了统计学上显著的疫苗疗效直接估计.
- 斯派克瓦克斯获得了最高的P评分 (0.95),这表明在分析中表现优越.
结论:
- 在这种比较分析中,Spikevax成为了对COVID-19最有效的疫苗.
- 该研究提供了一份排名的疫苗疗效清单,突出了像Spikevax,Comirnaty和Sputnik这样的表现最好的疫苗.
- 这些发现支持多样化,高效的疫苗在全球抗击COVID-19战略中的作用.
更多相关视频
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Dose-Response Relationship: Potency and Efficacy
4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K
Comparing the Survival Analysis of Two or More Groups
117
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
117
Bioequivalence: Overview
907
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
907
Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Hazard Ratio
76
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
76


